Bladder cancer biomarker proteins

Jérôme Garin (Inventor), Christophe Masselon (Inventor), Antonia Vlahou (Inventor), Bruno Domon (Inventor), Elodie Duriez (Inventor), Francois Radvanyi (Inventor), Yves Allory (Inventor), Nuria Marquez Cid (Inventor), Magali Mirari Court (Inventor), Riera Malatas (Inventor), Aurélie Kamoun (Inventor), Manousos Makrydakis (Inventor), Ieronimos Zoidakis (Inventor)

    Research output: Patent

    Abstract

    The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.
    Original languageEnglish
    IPCWO 2017/109171
    Publication statusPublished - 29 Jun 2017

    Fingerprint

    Dive into the research topics of 'Bladder cancer biomarker proteins'. Together they form a unique fingerprint.

    Cite this